A carregar...
Telaprevir/boceprevir era: From bench to bed and back
Hepatitis C virus (HCV) infects approximately 200 million people worldwide. Interferon-based therapies have dominated over the past two decades. However, the overall response rates remain suboptimal. Thanks to the tremendous effort from both academia and industry, two serine protease inhibitors tela...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Co., Limited
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501765/ https://ncbi.nlm.nih.gov/pubmed/23180937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i43.6183 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|